Evidence map›Paper›PMID 32377988›Full record

ArticlePathology oncology research : POR2020

AT-rich Interaction Domain 1A Gene Variations: Genetic Associations and Susceptibility to Gastric Cancer Risk.

Jasiya Qadir, Sabhiya Majid, Mosin S Khan, Fouzia Rashid, Mumtaz Din Wani, Inshah Din, Haamid Bashir

Abstract read
PubMed Publisher
In one paragraph

Article in Pathology oncology research : POR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Potential Regulation ofInternational journal of molecular sciences · 2025
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jasiya QadirDepartment of Biochemistry and Research Centre University of Kashmir, Government Medical College Srinagar and Associated Hospitals , Srinagar, 190010, India.
Sabhiya MajidDepartment of Biochemistry and Research Centre University of Kashmir, Government Medical College Srinagar and Associated Hospitals , Srinagar, 190010, India. sabuumajid@gmail.com.
Mosin S KhanDepartment of Biochemistry and Research Centre University of Kashmir, Government Medical College Srinagar and Associated Hospitals , Srinagar, 190010, India.
Fouzia RashidDepartment of Clinical Biochemistry, University of Kashmir, 190006, Srinagar, India.
Mumtaz Din WaniDepartment of Surgery, Government Medical College Srinagar and Associated Hospitals, 190010, Srinagar, India.
Inshah DinDepartment of Biochemistry and Research Centre University of Kashmir, Government Medical College Srinagar and Associated Hospitals , Srinagar, 190010, India.
Haamid BashirDepartment of Biochemistry and Research Centre University of Kashmir, Government Medical College Srinagar and Associated Hospitals , Srinagar, 190010, India.
Government Medical College · INUniversity of Kashmir · IN

Funding

Department of Biochemistry, Government Medical College Srinagar-190010 201 of 2018
6 · The paper itself

Abstract

AT-rich interaction domain containing protein 1A (ARID1A), has recently emerged as a novel class of gene which acts as a potent tumor suppressor in numerous types of cancers such as Gastric, Breast, Ovarian, Colorectal, Lung cancers. ARID1A is involved in the regulation of various cellular processes such as proliferation, differentiation and DNA repair, yet its association with the susceptibility of cancer remains unknown. Here, we aimed to analyse the association of the ARID1A variants (Pro912Thr, Gln944Lys and Gln920Ter) with the risk of Gastric cancer (GC) in Kashmiri population. The study included 103 confirmed cases of GC and 163 normal controls. The genotypes were studied using Polymerase Chain Reaction. Different bioinformatic predictive tools were also used to analyse the possible effect of these SNP's on the resultant protein. The Pro912Thr and Gln920Ter variants of ARID1A showed significant difference in genotypic and allelic frequencies between the GC cases and controls (P < 0.05), whereas, the data did not reveal any correlation between Gln944Lys variant and Gastric cancer risk. Both Pro912Thr and Gln920Ter SNP's follow "Dominant mode of inheritance". In Silico analysis predicted that amino acid substitution of Pro912Thr SNP decreases the protein stability thus changing the functional properties of resultant protein, so backing the possibility of damaging effect of this SNP. Our study suggests that Pro912Thr and Gln920Ter SNP's of ARD1A gene are associated with increased risk of GC in Kashmiri population.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideBiomarkers, TumorCase-Control StudiesDNA-Binding ProteinsFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisProspective StudiesRisk FactorsStomach NeoplasmsTranscription FactorsARID1A protein, humanBiomarkers, TumorDNA-Binding ProteinsTranscription FactorsARID1A; Gastric cancer; Pro912ThrGln920TerGln944LysKashmiri Population

Identifiers

PMID32377988
OpenAlexW3023321893

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.